The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kcif Co-investment Fund Kb since 2020.
The trader's CIK number is 1789966.
At the time of the last reporting, Kcif Co-investment Fund Kb was the 10% Owner of Aprea Therapeutics, Inc.. (stock ticker symbol APRE).
Also see all insider trading activities at Aprea Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | APRE | 0 | $0 | 452,251 | $14,930,463 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-07 | APRE | Sale | 241,703 | 34.55 | 8,350,838 |
| 2020-04-13 | APRE | Sale | 210,548 | 31.25 | 6,579,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kcif Co-investment Fund Kb (10% Owner of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.